As of Jul 31
| -0.0299 / -5.44%|
The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +1,053.85% increase from the last price of 0.52.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.